ELCO Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ELCO Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,126	Closed	-$230K	–	171
2019 Q1	$230K	Buy	+2,126	New	+$212K	0.14%	129
2018 Q4	–	Sell	-2,126	Closed	-$209K	–	145
2018 Q3	$209K	Hold	2,126	–	–	0.11%	136
2018 Q2	$246K	Hold	2,126	–	–	0.13%	121
2018 Q1	$210K	Hold	2,126	–	–	0.12%	128
2017 Q4	$223K	Hold	2,126	–	–	0.12%	135
2017 Q3	$240K	Hold	2,126	–	–	0.14%	120
2017 Q2	$238K	Hold	2,126	–	–	0.14%	126
2017 Q1	$248K	Hold	2,126	–	–	0.13%	132
2016 Q4	$224K	Sell	2,126 -4	-0.2%	-$419	0.12%	127
2016 Q3	$235K	Buy	+2,130	New	+$282K	0.09%	123

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ELCO Management's TARO Position: Q2 2019 in Review

ELCO Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019, closing a stake of 2,126 shares — an estimated $230K sold.

ELCO Management first reported a position in TARO in Q3 2016 and held it in 10 quarters. The position peaked at $248K in Q1 2017. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

ELCO Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2019 after selling out during the quarter.
ELCO Management sold 2,126 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $230K.
ELCO Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 10 quarters.
ELCO Management's Taro Pharmaceutical Industries Ltd. position peaked at $248K in Q1 2017.
105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on ELCO Management's 13F filing for Q2 2019, filed 1 Aug 2019.